Provided by Tiger Fintech (Singapore) Pte. Ltd.

Creative Medical Technology Holdings, Inc.

1.93
-0.0396-2.01%
Volume:63.83K
Turnover:125.49K
Market Cap:4.99M
PE:-0.52
High:2.06
Open:1.95
Low:1.92
Close:1.97
Loading ...

Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development

GlobeNewswire
·
05 Feb

Creative Medical reports data from first cohort in Phase 1/2 CELZ-201-DDT trial

TIPRANKS
·
30 Jan

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data From First Cohort in Phase 1/2 Trial of Celz-201-Ddt for Chronic Back Pain

THOMSON REUTERS
·
30 Jan

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain

GlobeNewswire
·
30 Jan

Creative Medical Gets Safety Approval in FDA-Cleared Back Pain Treatment Trial

MT Newswires Live
·
14 Nov 2024

Creative Medical advances FDA cleared ADAPT trial with independent review

TIPRANKS
·
13 Nov 2024

BRIEF-Creative Medical Technology Holdings, Inc. Advances FDA Cleared Adapt Clinical Trial With Positive Independent Review, Validating The Safety And Potential Of CELZ-201 For Chronic Lower Back Pain Treatment

Reuters
·
13 Nov 2024

Creative Medical Technology Holdings, Inc. Advances FDA Cleared Adapt Clinical Trial With Positive Independent Review, Validating the Safety and Potential of Celz-201 for Chronic Lower Back Pain Treatment

THOMSON REUTERS
·
13 Nov 2024

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment

GlobeNewswire
·
13 Nov 2024

Creative Medical Technology Holdings Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.02 loss in 3Q 2023)

Simply Wall St.
·
10 Nov 2024

Creative Medical Technology Holdings Inc expected to post a loss of 87 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Creative Medical Technology files to sell 837,104 shares of common for holders

TIPRANKS
·
09 Nov 2024